Robert Stott

Philadelphia

Executive Editor at Healio Rheumatology

Executive Editor at HemOnc Today

Executive Editor at Healio

Featured in: Favicon

healio.com

Articles

Yuflyma becomes fourth Humira biosimilar to receive interchangeability status

1 week ago | healio.com | Rebecca Forand |Robert Stott

Key takeaways: Celltrion’s Yuflyma is a high concentration, citrate-free formulation of adalimumab. It is the ninth Humira biosimilar approved by the FDA and the fourth to receive interchangeability status. The FDA has accepted Yuflyma as an interchangeable biosimilar to adalimumab for the treatment of multiple chronic inflammatory diseases, Celltrion USA announced in a press release.
Tremfya’s FDA win as fully subcutaneous option for Crohn’s may pave way to eclipse Stelara

1 month ago | healio.com | Robert Stott |Heather Biele

Key takeaways:Tremfya is the first approved IL-23 inhibitor to offer both IV and fully subcutaneous induction regimens. This approval for Crohn’s disease may make Tremfya a direct competitor with Stelara. The FDA has approved Tremfya as the “first and only” interleukin-23 inhibitor that offers both IV and fully subcutaneous induction options for the treatment of moderately to severely active Crohn’s disease, Johnson & Johnson reported.
AGA stuck in neutral on AI-assisted colonoscopy guidance; ‘close tradeoff’ of cost/benefit

1 month ago | healio.com | Robert Stott |Heather Biele

Key takeaways:The AGA made no recommendation for or against the use of AI-driven polyp detection in colonoscopy. Insufficient evidence to determine if polyp detection via AI prevented colorectal cancer.
ACG unveils gastric premalignancy guidelines aligned with colon, esophagus surveillance

1 month ago | healio.com | Robert Stott |Heather Biele

Key takeaways: H. pylori eradication is strongly encouraged for patients with gastric premalignant conditions. High-quality endoscopic evaluation of the stomach is recommended to identify gastric premalignant conditions. The ACG has released its first guidance for gastric premalignant conditions, such as atrophic gastritis, gastric intestinal metaplasia and dysplasia, in sync with surveillance recommendations established for the colon and esophagus.
ACG revises gastric premalignancy guidelines to align with colon, esophagus surveillance

1 month ago | healio.com | Robert Stott

Key takeaways: H. pylori eradication is strongly encouraged for patients with gastric premalignant conditions. High-quality endoscopic evaluation of the stomach is recommended to identify gastric premalignant conditions. The ACG has revised its guidance for gastric premalignant conditions, such as atrophic gastritis, gastric intestinal metaplasia, dysplasia and certain epithelial polyps, to better align with colon and esophagus surveillance recommendations.
US Multi-Society Task Force on CRC revamps colonoscopy bowel prep to set new ‘benchmark’

1 month ago | healio.com | Robert Stott |Heather Biele

Key takeaways: Endoscopy units and endoscopists are recommended to reach a bowel preparation adequacy rate of 90%. Adjunctive use of oral simethicone is suggested, but routine nonsimethicone adjuncts are not. The U.S. Multi-Society Task Force on Colorectal Cancer has released updated guidance establishing a “reasonable benchmark” for the quality of bowel preparation prior to a colonoscopy exam.
VIDEO: ACG presidential roundtable explores ‘creative ways’ to tackle GI shortage

2 months ago | healio.com | Robert Stott |Heather Biele

In a Healio video exclusive, Edward V. Loftus Jr., MD, discusses the looming threat of gastroenterology workforce shortage, alongside insights from a roundtable of ACG presidents on how we might still avoid it. “I think we all feel it on some level,” Loftus said. “By some estimates, there is projected to be a shortage of over 1,000 gastroenterologists over the next few years.
AGA urges antiviral prophylaxis for patients at high risk for hepatitis B reactivation

2 months ago | healio.com | Robert Stott |Heather Biele

Key takeaways: AGA guidance strongly recommends antiviral prophylaxis for patients at high risk for hepatitis B reactivation. At-risk patients not recommended for antiviral prophylaxis should be actively monitored. In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients receiving immunosuppressive therapy.
IBD drug market rattles as Lilly’s Omvoh nabs FDA approval for second IL-23p19 in Crohn’s

Jan 16, 2025 | healio.com | Robert Stott

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
Ocaliva down but not out: A timeline of FDA troubles for a once-promising PBC contender

Dec 31, 2024 | healio.com | Robert Stott

You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Eight years ago, Ocaliva was a prospective lifesaver for patients with primary biliary cholangitis who failed to adequately respond to first-line ursodeoxycholic acid.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Robert Stott

Articles

Yuflyma becomes fourth Humira biosimilar to receive interchangeability status

Tremfya’s FDA win as fully subcutaneous option for Crohn’s may pave way to eclipse Stelara

AGA stuck in neutral on AI-assisted colonoscopy guidance; ‘close tradeoff’ of cost/benefit

ACG unveils gastric premalignancy guidelines aligned with colon, esophagus surveillance

ACG revises gastric premalignancy guidelines to align with colon, esophagus surveillance

US Multi-Society Task Force on CRC revamps colonoscopy bowel prep to set new ‘benchmark’

VIDEO: ACG presidential roundtable explores ‘creative ways’ to tackle GI shortage

AGA urges antiviral prophylaxis for patients at high risk for hepatitis B reactivation

IBD drug market rattles as Lilly’s Omvoh nabs FDA approval for second IL-23p19 in Crohn’s

Ocaliva down but not out: A timeline of FDA troubles for a once-promising PBC contender

Contact details

Emails

Socials & Sites